 | Up a level |
Suana, A J; Tuffin, G; Frey, B M; Knudsen, L; Mühlfeld, C; Rödder, S; Marti, H-P (2011). Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis. Journal of pharmacology and experimental therapeutics, 337(2), pp. 411-22. Bethesda, Md.: American Society for Pharmacology and Experimental Therapeutics 10.1124/jpet.110.176222
Knudsen, L; Geiser, T (2008). Pathogenesis and diagnostic work-up of patients with idiopathic pulmonary fibrosis. Respiratory medicine, 101(12), pp. 2534-2540. London: Elsevier 10.1016/j.rmed.2007.07.012
Gazdhar, A; Knudsen, L; Gugger, M; Ochs, M; Geiser, T (2010). Bone marrow derived stem cells attenuate bleomycin induced lung fibrosis in rat lungs. In: Swiss stem cell network meeting. Basel: Swiss stem cell network meeting
Gazdhar, A; Knudsen, L; Gugger, M; Ochs, M; Geiser, T (2010). Modified BMSC improve lung fibrosis in bleomycin injured rat lungs. In: Annual Swiss Pulmonary Medicine Meeting. Lausanne: Annual Swiss Pulmonary Medicine Meeting
Gazdhar, A; Knudsen, L; Gugger, M; Ochs, M; Geiser, T (2010). Modified BMSC attenuate fibrosis in bleomycin injured rat lungs. In: European Respiratory Meeting. Barcelona: European Respiratory Meeting
Gazdhar, A; Knudsen, L; Gugger, M; Ochs, M; Geiser, T (2010). BMSC and modified BMSC as novel therapeutics for lung fibrosis. In: Pneumo Update Conference. Innsbruck: Pneumo Update Conference
Knudsen, L; Temuri, A; Gazdhar, A; Schmid, R; Ochs, M; Geiser, T (2009). The impact of human hepatocyte growth factor 8hHGF in bleomycin-induce pulmonary fibrosis - morphometric analysis. In: Pneumo Update Conference. Innsbruck.
